design, in vitro and in vivo characterization of chitosan-dextran sulfate microparticles for oral delivery of insulin

Journal of Bioequivalence and Bioavailability

Volumn 3, Issue 10, 2011, Pages 244-250

  Pechenkin, Mikhail A ^a   Balabushevich, Nadezhda G ^a   Zorov, Ivan N ^a   Staroseltseva, Lubov K ^b   Mikhalchik, Elena V ^c   Izumrudov, Vladimir A ^a   Larionova, Natalia I ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; DEXTRAN SULFATE; RECOMBINANT HUMAN INSULIN;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STABILITY; EXPERIMENTAL RABBIT; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROENCAPSULATION; MUCOADHESION; NONHUMAN; PANCREAS JUICE; PH MEASUREMENT; RAT; SMALL INTESTINE MUCOSA; STOMACH MUCOSA;

EID: 84857073652     PISSN: None     EISSN: 09750851     Source Type: Journal    
DOI: 10.4172/jbb.1000094     Document Type: Article

References (36)

1. Zubaerova DK, Larionova NI (2008) Noninvasive Insulin Delivery Systems. Biomed Khim 2: 346-355
2. Nash G (2008) http://www.generex.com/press_release_desc.php?id=65.
3. Haverstick DM, Dickemper D, Gold AH (1979) Cycloheximide inhibition of insulin control of liver glycogen synthase b into a conversion. Biochem Biophys Res Commun 87: 177-183.
4. Carino GP, Mathiowitz E (1999) Oral insulin delivery. Adv Drug Deliv Rev 35: 249-257.
5. Hamman JH, Enslin GM, Kotzé AF (2005) Oral delivery of peptide drugs: barriers and developments. BioDrugs 1: 165-177.
6. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 78: 43-48.
7. Prabaharan M, Mano JF (2005) Chitosan-based particles as controlled drug delivery systems. Drug Deliv 12: 41-57.
8. Ziv E, Bendayan M (2000) Intestinal absorption of peptides through the enterocytes. Microsc Res Tech 49: 346-352.
9. Dodane V, Amin Khan M, Merwin JR (1999) Effect of chitosan on epithelial permeability and structure. Int J Pharm 182: 21-32.
10. st century: a review. S.T.P. Pharma Sci 10: 5-22.
11. Sarmento B, Ribeiro A, Veiga F, Ferreira D (2006) Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B: Biointerfaces 53: 193-202.
12. Pan Y, Li Y, Zhao H, Zheng J, Xu H, et al. (2002) Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249: 139-147.
13. Balabushevich NG, Izumrudov VA, Zorov IN, Larionova NI (2010) Development of chitosan-containing polyelectrolyte microparticles for peroral protein delivery. Biopharm J 2: 35-41. [in Russian with English abstract].
14. Fan YF, Wang YN, Fan YG, Ma JB (2006) Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-bylayer adsorption. Int J Pharm 324: 158-167.
15. Balabushevich NG, Lebedeva OV, Vinogradova OI, Larionova NI (2006) Polyelectrolyte assembling for protein microencapsulation. J Drug Del Sci Tech 16: 315-319.
16. Balabushevich NG, Vikhoreva GA, Mikhal'chik EV, Larionova NI (2010) Fabrication and properties of pH-sensitive nanostructured polyelectrolyte microparticles loaded with insulin. Moscow University Chemistry Bulletin 65: 148-153.
17. Balabushevich NG, Pechenkin MA, Zorov IN, Shibanova ED, Larionova NI (2011) Mucoadhesive polyelectrolyte microparticles containing recombinant human insulin and its analogs aspart and lispro. Biochemistry (Moscow) 76: 327-331.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
19. Dubois M, Gilse A, Hamilton SK, Robers PA, Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350-356.
20. Larionova NI, Zubaerova DK, Guranda DT, Pechyonkin MA, Balabushevich NG (2009) Colorimetric assay of chitosan in presence of proteins and polyelectrolytes by using o-phthalaldehyde. Carb Polym 75: 724-727.
21. Marschütz MK, Bernkop-Schnürch A (2000) Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials 21: 1499-1507.
22. Bernkop-Schnürch A (2005) Mucoadhesive systems in oral drug delivery. Drug Discov Today: Technologies 2: 83-87.
23. Schwert GW, Takenaka Y (1955) A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta 16: 570-575.
24. Blundell T, Dodson G, Hodgkin D, Mercola D (1972) Insulin: the structure in the crystal and its reflection in chemistry and biology. Adv Protein Chem 26: 279-402.
25. Tanford C, Kirkwood JG (1957) Theory of protein titration curves. I. General equations for impenetrable spheres. J Am Chem Soc 79: 5333-5339.
26. Tanford C, Roxby R (1972) Interpretation of protein titration curves. Application to lysozyme. Biochemistry 11: 2192-2198.
27. Peppas NA, Sahlin JJ (1996) Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 17: 1553-1561.
28. Izumrudov VA, Volkova IF, Gorshkova MY (2010) Chitosan-based Polyelectrolyte Complexes Soluble in Enzyme-friendly pH Range Macromol Chem Phys 211: 453-460.
29. Balabushevich NG, Larionova NI (2004) Fabrication and Characterization of Polyelectrolyte Microparticles with Protein. Biochemistry Moscow 69: 757-762.
30. Cui F, Zhang L, Zheng J, Kawashima Y (2004) A study of insulin-chitosan complex nanoparticles used for oral administration. J Drug Del Sci Tech 14: 435-439.
31. Marschütz MK, Calceti P, Bernkop-Schnürch A (2000) Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res 17: 1468-1474.
32. Valuev IL, Sytov GA, Valuev LI, Valueva TA, Ul'ianova MV, et al. (2001) Inhibitors of proteolytic enzymes in the therapy of diabetes. Vopr Med Khim 47: 132-137. [in Russian with English abstract]
33. Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16: 351-380.
34. Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP (1990) Nanocapsules as carriers for oral peptide delivery. J Control Rel 13: 233-239.
35. Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R (2007) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8: 3054-3060.
36. Ma Z, Lim TM, Lim LY (2005) Pharmacological activity of peroral chitosaninsulin nanoparticles in diabetic rats. Int J Pharm 293: 271-280.